12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several health care stocks showed significant movement. Sharps Technology and DMK Pharmaceuticals led the gainers with over 20% increases in their stock prices, while Exicure and Yield10 Bioscience were among the top losers, experiencing declines of over 6%. Notably, Arrowhead Pharma and Varex Imaging reported their Q1 earnings, influencing their stock movements.
February 06, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Arrowhead Pharma's stock declined by 6.46% following its Q1 earnings report, indicating investor reaction to the financial results.
The decline in Arrowhead Pharma's stock price post-earnings suggests that the financial results may not have met investor expectations, leading to a negative short-term impact.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
NEGATIVE IMPACT
Varex Imaging's stock fell 5.61% after its Q1 earnings were announced, possibly due to investor dissatisfaction with the results.
Varex Imaging's stock price decrease following its Q1 earnings report suggests that the results may have been below investor expectations, negatively affecting the stock in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
POSITIVE IMPACT
DMK Pharmaceuticals experienced a 22.84% rise in its stock price, indicating potential positive developments or investor optimism.
The sharp increase in DMK Pharmaceuticals' stock price suggests that investors may be reacting to positive news or developments related to the company.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Sharps Technology stock surged 27.9% in after-market trading, reflecting positive investor sentiment.
The significant increase in Sharps Technology's stock price indicates strong investor interest, potentially due to positive market sentiment or recent company developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90